Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MyD88

MyD88 (Myeloid differentiation primary response gene 88) is a protein that is encoded by the MYD88 gene in humans. Available evidence suggests that MYD88 is dispensable for human resistance to common viral infections and to all but a few pyogenic bacterial infections, demonstrating a major difference between mouse and human immune responses. MyD88 is an essential adaptor protein in the IL-1R1 signaling pathway. MyD88 may define a family of signal transduction molecules with an ancestral function in the activation of the immune system. MyD88 functions as a pure adaptor linking the IL-1R1 to downstream IRAK kinases. Mutation in MYD88 at position 265 leading to a change from leucine to proline have been identified in many human lymphomas including ABC subtype of Diffuse Large B-cell Lymphoma and Waldenstrom's Macroglobulinemia.

Schaftoside
Shaftoside, APIGENIN-6-GLUCOSIDE-8-ARABINOSIDE
T389851938-32-0
Schaftoside (APIGENIN-6-GLUCOSIDE-8-ARABINOSIDE) has antioxidant and anticancer activity.
  • $35
In Stock
Size
QTY
TargetMol | Citations Cited
Heclin
T24136890605-54-6
Heclin is an inhibitor of HECT E3 ubiquitin ligase that acts by inhibiting Smurf2, Nedd4, and WWP1 with IC50 values of 6.8, 6.3, and 6.9 μM, respectively.
  • $36
In Stock
Size
QTY
Raffinose
Melitriose, Melitose
T8144512-69-6
Raffinose (Melitriose) is an indigestible short-chain oligosaccharide, a trisaccharide composed of galactose, glucose and fructose, found in many plants. It can be hydrolyzed by α-galactosidase (α-GAL) to D-galactose and sucrose.
  • $42
In Stock
Size
QTY
EM 163
T411421206480-93-4In house
EM 163 is a TIR-TIR interaction inhibitor, which is a TIR (Toll/interleukin-1 receptor) structural domain mimic of the MyD88 protein. EM 163 targets the TIR structural domain in the IL-1 receptor and blocks the interaction with MyD88. EM 163 inhibits the production of inflammatory cytokines in vivo caused by staphylococcal enterotoxin B (SEB). EM 163 protects mice from SEB shock-induced death. In rat hippocampal neurons in vitro, EM 163 blocked the activation of p38 and the inhibitory effect of IL-1β on chemically induced long-term potentiation (LTP)-triggered protein synthesis.
  • $123
In Stock
Size
QTY
Tomaralimab
OPN-305
T769751449294-76-1
Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2, used to study myelodysplastic syndromes (MDS).
  • $157
In Stock
Size
QTY
T6167923
T130632437475-16-4
T6167923 is a potent, selective inhibitor of MyD88-dependent signaling pathways. It achieves this by directly binding to the Toll/IL1 receptor (TIR) domain of MyD88, preventing MyD88 homodimer formation. Subsequently, T6167923 impedes NF-κB driven Staphylococcus enterotoxin AP (SEAP) activity and boasts improved anti-inflammatory effects, with IC50s values of 2.7 μM for IFN-γ, 2.9 μM for IL-1β, and 2.66 μM each for IL-6 and TNF-α, demonstrating its efficacy across multiple inflammatory mediators [1].
  • $93
In Stock
Size
QTY
Grossamide
TN417180510-06-1
Grossamide (GSE) Grossamide is a lignan amide derived from thioguanosine.6-Thioguanosine (GSE) is a selective and potent miR-210 (miRNA-210) inhibitor.6-Thioguanosine (GSE) is a selective and potent miR-210 (miRNA-210) inhibitor.6-Thioguanosine (GSE) is a selective and potent miR-210 (miRNA-210) inhibitor that inhibits pre-miR-210 processing and induces apoptosis in breast cancer cells.
  • $449
Inquiry
Size
QTY
CA-4948
Emavusertib
T90271801344-14-8
CA-4948 (Emavusertib) is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.
  • $30
In Stock
Size
QTY
TJ-M2010-5
T97651357471-57-8
TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain to interfere with its homodimerization and suppress MyD88 signaling. TJ-M2010-5 can be used in myocardial [ischemia/reperfusion] injury studies.
  • $31
In Stock
Size
QTY
CL075
CL-075, 3M002
T27034256922-53-9
CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-κB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN).
  • $34
In Stock
Size
QTY
MyD88-IN-1
T773532911609-80-6
MyD88-IN-1 is a potent MyD88 inhibitor with anti-inflammatory activity, inhibiting downstream pathways such as the NF-κB pathway of the Toll-like receptor (TLR) and interleukin-1 (IL-1) receptor family. MyD88-IN-1 may be used in the study of cancer and inflammation treatment.
  • $48
In Stock
Size
QTY
Smurf1-IN-A01
A01
T169041007647-73-5
Smurf1-IN-A01 (A01) is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (Kd: 3.664 nM) that enhances BMP-2 responsiveness by preventing Smurf1-mediated Smad1/5 degradation.
  • $32
In Stock
Size
QTY
TargetMol | Citations Cited
Chloranil
p-Chloranil
T80673118-75-2
Chloranil (tetrachloro-p-benzoquinone) triggers inflammation and neurological dysfunction through Toll-like receptor 4 signaling and can be used to model inflammation in mice.
  • $29
In Stock
Size
QTY
UF010
T3205537672-41-6
UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μM and 1.5 μM for HDACs 3, 2, 1 and 8, respectively.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Sale
DHBP
Benzoresorcinol
T7338L131-56-6
DHBP (Benzoresorcinol) is an WalKR TCS activator. It works via targeting walk and selectively promoting the lysostaphin-induced lysis activity of the Newman wild-type strain.
  • $40
In Stock
Size
QTY
6-Methoxyflavone
TN317526964-24-9
6-Methoxyflavone is one of the methoxyflavone isolated form Pimelea decora. Synthesis of 6-methoxyflavone from p-dihydroxybenzene has been reported.
  • $31
In Stock
Size
QTY
Copper Sulfate Pentahydrate
TSH-000557758-99-8
Copper Sulfate Pentahydrate has a variety of antibacterial activities, and has inhibitory activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, etc.
  • $29
In Stock
Size
QTY
TLR1
T13932566914-00-9
TLR1 is a cell-penetrating Toll/IL-1 receptor/resistance (TIR) domain/BB-Loop mimic and inhibits IL-1 receptor-mediated responses.
  • $51
In Stock
Size
QTY
TargetMol | Inhibitor Sale
D228
D 228
T2005512676188-98-8
D228, a natural product from Chimonanthus salicifolius, is an orally available anti-inflammatory agent with favorable inhibitory activity on B and T lymphocytes, down-regulation of MyD88/TRAF6/p38 and up-regulation of IL-10 to reduce inflammation, and can be used for the treatment of inflammatory bowel disease (IBD).
  • $50
In Stock
Size
QTY
Trehalose-6,6'-dibehenate
Trehalose Dibehenate, TDB, 22:0 Trehalose
T8756166758-35-8
Trehalose-6,6'-dibehenate, a bioactive glycolipid, is applicable for the preparation of vaccine adjuvant [1].
  • Inquiry Price
Inquiry
Size
QTY
Emavusertib hydrochloride
CA-4948 hydrochloride
T863662376399-42-5
Emavusertib (CA-4948) hydrochloride, a selective and potent IRAK4/FLT3 inhibitor, is designed for oral administration. It achieves an IC 50 of 57 nM against IRAK4 in a FRET kinase assay and demonstrates anti-tumor activity [1] [2] [3].
  • Inquiry Price
3-6 months
Size
QTY
MyD88-IN-4
T2137211801552-15-7
MyD88-IN-4 is a MyD88 inhibitor. It exerts antiviral effects by upregulating IFN-β and demonstrates anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines. MyD88-IN-4 prevents the formation of MyD88 homodimers and interferes with its interaction with IRF3/IRF7. In a mouse model infected with VEEV TC-83, MyD88-IN-4 shows efficacy against encephalitic alphavirus infections by reducing viral replication and increasing survival rates. This compound is applicable for research on alphavirus infections, bacterial toxin-related diseases, and sepsis.
  • Inquiry Price
10-14 weeks
Size
QTY
MyD88-IN-3
T213436
MyD88-IN-3 is an orally active, selective MyD88 inhibitor that specifically targets the TIR domain of MyD88 (KD= 28.5 μM). It prevents MyD88 self-aggregation and its interaction with TLRs, thereby suppressing the activation of the MAPK and NF-κB pathways. MyD88-IN-3 exhibits significant anti-inflammatory effects and effectively alleviates symptoms of acute lung injury in CLP (cecal ligation and puncture) and LPS (lipopolysaccharide)-induced ALI models. This compound is valuable for ALI research.
  • Inquiry Price
Inquiry
Size
QTY
TSI-13-57
TSI 13-57
T697192257427-45-3
TSI-13-57 is a MyD88 inhibitor or pan-TLR inhibitor that suppresses MyD88 TIR domain dimerization without affecting MyD88-receptor interactions. TSI-13-57 inhibits LPS-induced TNF-α (IC50 = 6.73 mM).
  • $243
In Stock
Size
QTY